APOC1 and hepatocellular carcinoma: (Van Campenhout et al., 2020) Inhibiting APOC1 can promote the polarization of TAMs towards inflammatory macrophages via the ferroptosis pathway, thereby restoring an antitumor immune microenvironment and improving anti-PD1 immunotherapy for HCC.